valtresto sacubitril/valsartan 24/26 mg film-coated tablet bottle pack
pharmacor pty ltd - valsartan, quantity: 25.7 mg; sacubitril, quantity: 24.3 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; purified talc; hyprolose; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 97/103 mg film-coated tablet blister pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; hyprolose; magnesium stearate; purified talc; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 97/103 mg film-coated tablet bottle pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; purified talc; microcrystalline cellulose; sodium starch glycollate type a; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 49/51 mg film-coated tablet blister pack
pharmacor pty ltd - sacubitril, quantity: 48.6 mg; valsartan, quantity: 51.4 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; hyprolose; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 49/51 mg film-coated tablet bottle pack
pharmacor pty ltd - sacubitril, quantity: 48.6 mg; valsartan, quantity: 51.4 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; sodium starch glycollate type a; purified talc; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 24/26 mg film-coated tablet blister pack
pharmacor pty ltd - sacubitril, quantity: 24.3 mg; valsartan, quantity: 25.7 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; purified talc; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
ultrasound system, imaging, general-purpose
medical technologies aust pty ltd - 40761 - ultrasound system, imaging, general-purpose - ultrasound for external observation of tissue, organs and bone
bluedop medical - noninvasive vascular ultrasound system, battery-powered
diverse devices pty ltd - 44311 - noninvasive vascular ultrasound system, battery-powered - this device is hermetically sealed poplar probe, used to measure abi(ankle brachial index), perfusion , pressure and vascular reserve. the probe is administered on the surface of the skin
evoltra clofarabine 20 mg/20 ml concentrated solution for infusion vial
sanofi-aventis australia pty ltd - clofarabine, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium chloride - treatment of acute lymphocytic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens. this use is based on the induction of complete responses.
ultrasonic dental surgical system - ultrasonic dental surgical system
more group pty ltd -